1. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 84-8.
2. Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL: CRC Press, 1985, 113.
3. Mességué M. Of Men and Plants. New York: Macmillian Co, 1973.
4. Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL: CRC Press, 1985, 113.
5. Baumann JC. Effect of Chelidonium, Curcuma, absinth and Carduus marianus on the bile and pancreatic secretion in liver diseases. Med Monatsschr 1975;29:173-80 [in German].
6. Hiller KO, Ghorbani M, Schilcher H. Antispasmodic and relaxant activity of chelidonine, protopine, coptisine, and Chelidonium majus extracts on isolated guinea-pig ileum. Planta Med 1998;64:758-60 [letter].
7. Hriscu A, Galesanu MR, Moisa L. Cholecystokinetic action of an alkaloid extract of Chelidonium majus. Rev Med Chir Soc Med Nat Lasi 1980;84:559-61 [in Romanian].
8. Vavreckova C, Gawlik I, Muller K. Benzophenanthridine alkaloids of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism. Planta Med 1996;62:397-401.
9. Sokoloff B, Saelhof CC, Takeuchi Y, Powella R. The antitumor factors present in Chelidonium majus L. I. Chelidonine and protopine. Growth 1964;28:225-31.
10. Molochko VA, Lastochkina TM, Krylov IA, Brangulis KA. The antistaphylococcal properties of plant extracts in relation to their prospective use as therapeutic and prophylactic formulations for the skin. Vestn Dermatol Venerol 1990;(8):54-6 [in Russian].
11. Mitra S, Gole K, Samajdar K, et al. Antihepatotoxic activity of Chelidonium majus. Int J Pharmacognosy 1992;30:125-8.
12. Mitra S, Sur RK, Roy A, Mukherjee AS. Effect of Chelidonium majus L on experimental hepatic tissue injury. Phytother Res 1996;10:354-6.
13. Ritter R, Schatton WFH, et al. Clinical trial on standardized celandine extract in patients with functional epigastric complaints: Results of placebo-controlled double-blind trial. Comp Ther Med 1993;1:189-93.
14. Kniebel R, Urlacher W. Z Allgemeinmed 1993;69:680-4.
15. Bone K (ed). Chelidonium--A medicinal poppy. MediHerb Professional Newsletter 1996;49:1-3.
16. Susak YM, Zemskov VS, Yaremchuk OY, et al. Comparison of chemotherapy and x-ray therapy with Ukrain monotherapy for colorectal cancer. Drugs Exp Clin Res 1996;22:115-22.
17. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 84-8.
18. Bone K (ed). Chelidonium--A medicinal poppy. MediHerb Professional Newsletter 1996;49:1-3.
19. Ritter R, Schatton WFH, et al. Clinical trial on standardized celandine extract in patients with functional epigastric complaints: Results of placebo-controlled double-blind trial. Comp Ther Med 1993;1:189-93.
20. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 84-8.
21. McGuffin M, Hobbs C, Upton R, Goldberg A (eds). American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press, 1997.
22. Etxenagusia MA, Anda M, Gonzalez-Mahave I, et al. Contact dermatitis from Chelidonium majus (greater celandine). Contact Derm 2000;43:47.
23. McGuffin M, Hobbs C, Upton R, Goldberg A (eds). American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press, 1997.
24. Benninger J, Schneider HT, Schuppan D, et al. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterol 1999;117:1234-7.